baber/WOPTO huggingface dataset:
Patent NZ-247054-A (NZ)
Title: Immunological determination of haemoglobin derivative in a blood sample including test kits and haemolysis reagents for use in such method.
Inventor: KARL JOHANN
IPC: G01N33/531
Filed: 1993-03-03
Abstract: The invention relates to a method for determining the content of a particular haemoglobin derivative in a blood sample. Specifically, the invention relates to a method for determining the content of haemoglobin derivatives, such as glycated haemoglobin (HbAlc), which require separate determination of the total haemoglobin content and determination of the haemoglobin derivative, in order to determine the content of the derivatised haemoglobin in the blood, and to a haemolysis reagent which is suitable for this purpose and contains an ionic detergent.
Patent NZ-247218-A (NZ)
Title: Connector for butt-jointing frusto-conical cable ends
Inventor: BRUNNER GUIDO
IPC: F16G11/04
Filed: 1993-03-22
Abstract: A termination device (3) for butt-connecting cables, consisting of a hollow structure (4) in the form of two opposing cone frustums with their minor bases arranged at the ends of the structure, which is cut into two equal half-shells (6,7) along a central plane and into the frusto-conical cavities of which there are inserted the frusto-conically enlarged ends (1',2') of said cables, said half-shells (6,7) being maintained joined together by two frusto-conical sleeves (8,9) mounted from the ends of the structure and themselves held in position by bolts (10) connecting together the radial flanges present at the facing ends of said sleeves (8,9). Modifications and preferred embodiments are also provided. <IMAGE>
Patent NZ-247233-A (NZ)
Title: Phenyl substituted benzimidazole or imidazo-[5,4-b]pyridine derivatives and pharmaceutical compositions thereof
Inventor: AXELSSON OSKAR
IPC: C07D235/08
Filed: 1993-03-24
Abstract: The present invention discloses compounds of the formula <CHEM>  wherein     X is C or N;     Y is C or N;     R<1><1> is hydrogen, hydroxy, or alkoxy; R<1><2> and R<1><3> are each independently hydrogen; halogen; CF3; CN; OH; alkyl; cycloalkyl; cycloalkylalkyl; alkenyl; alkynyl; alkoxy; phenylalkyl; amino; nitro; sulphamoyl; pipiridyl; pyrrolidinyl; acyl; CO2H; CO2-alkyl; CO-amino; NH-CO-alkyl; phenylsulphonyl which may be substituted with halogen, CF3, CN, OH, alkyl, alkenyl, alkynyl, alkoxy, amino, or nitro; phenyloxy which may be substituted with halogen, CF3, CN, OH, alkyl, alkenyl, alkynyl, alkoxy, amino, or nitro; phenylamino which may be substituted with halogen, CF3, CN, OH, alkyl, alkenyl, alkynyl, alkoxy, amino, or nitro; or aryl which may be substituted one or more times with halogen, CF3, CN, OH, alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, phenoxy, phenylalkyl, amino, nitro, sulphamoyl, pipiridyl, pyrrolidinyl, CO2H, CO2-alkyl, CO-amino, or NH-CO-alkyl; and R<4>, R<5>, R<6> and R<7> are each independently hydrogen; halogen; amino; nitro; CN; CF3; COOH; COO-alkyl; alkyl; acyl; alkoxy; -(CH2)n,-OH wherein n is 0, 1,2, or 3; -(CH2)m-O-alkyl wherein m is 0, 1,2, or 3; -(CH2)o-O-acyl wherein o is 0, 1,2, or 3; and that if X is N then R<4> is absent and that if Y is N then R<7> is absent;  or a pharmaceutically-acceptable addition salt thereof The compounds are useful as pharmaceuticals, for example, in the treatment of stroke, ischemia, anoxia, migraine and psychosis.
Patent NZ-263403-A (NZ)
Title: (oxa)cycloalkyl fused indole and benzofuran amines
Inventor: ANDERSSON BENGT RONNY
IPC: A61K31/403
Filed: 1994-03-21
Abstract: PCT No. PCT/US94/02800 Sec. 371 Date Sep. 7, 1995 Sec. 102(e) Date Sep. 7, 1995 PCT Filed Mar. 21, 1994 PCT Pub. No. WO94/21608 PCT Pub. Date Sep. 29, 1994A compound of formula (I) and pharmaceutically acceptable salts thereof, where Z is R3 and X and Y form (a), or X is R3 and Y and Z form (a) or (b); R1 and R2 are independently hydrogen, C1-6 alkyl, C3-7 cycloalkyl, -CH2-C3-7 cycloalkyl, phenyl (optionally substituted with halogen or C1-6 alkyl), -thiophenyl (optionally substituted with halogen or C1-6 alkyl), or C1-6 alkyl phenyl; R3 are independently hydrogen, halogen, -O-C1-6 alkyl or C1-6 alkyl; R4 is a valence bond, CH2 or oxygen; R5 and R6 are independently hydrogen, sulfur, -S-C1-6 alkyl, halogen, CON(R3)2, -COCF3, -CO-C1-6 alkyl, -CO phenyl, oxygen, -CHO, CN except that when Y and Z form (b), R1 and R2 are hydrogen or a C1-6 alkyl and R3 is hydrogen, then at least one of R5 and R6 must be other than hydrogen. These compounds and derivatives thereof exhibit dopamine-receptor stimulating activity in mammals.    <IMAGE>  (I)   <IMAGE>  (a)   <IMAGE>  (b)
Patent NZ-276069-A (NZ)
Title: Multilayered heat shrink film at least one layer of ethylene/alpha-olefin copolymer with more than one melting point and stretched in both machine and cross directions
Inventor: BUONGIORNO LIVIO
IPC: B29C55/02
Filed: 1994-10-28
Abstract: A method of making the a multilayer, biaxially oriented, heat shrinkable thermoplastic film includes a layer having between 50 and 100 parts by weight ethylene/alpha-olefin C4-C12 copolymer, and between 0 and 50 parts by weight of a polymer selected from polyolefin, and modified polyolefin, the layer having more than one melting point when detected by diffential scanning calorimetry according to ASTM D-3418; wherein the total thickness variation in the multilayer film is lower than ±10%.
Patent NZ-300073-A (NZ)
Title: Substituted arythio derivatives; medicaments; used as antibacterial and antiviral agents
Inventor: DOMAGALA JOHN MICHAEL
IPC: A61K31/63
Filed: 1995-07-11
Abstract: Arylthiol and dithiobisarylamide antibacterial and antiviral agents have the general formula   <IMAGE>   where A is monocyclic or bicyclic aryl which can contain up to 3 heteroatoms selected from O, S, and N, R1 and R2 are substituent groups, X is   <IMAGE>   or SO2NR4Z, Y is H or SZ when n is 1, a single bond when n is 2; R4 and Z can be hydrogen or alkyl.
Patent NZ-329973-A (NZ)
Title: Hand held or portable printing labeller comprising a endless conveyor belt that is resistant to wear
Inventor: MIKETA TSUTOMU
IPC: B41K3/06
Filed: 1997-08-06
Abstract: printer adapted to prevent damages such as wear and cracks to a printing endless belt (7) by not exerting an excessively large turning force thereon when the rotation of the printing endless belt (7) is restricted, and prevent a heavy load on the printing endless belt (7) by idly turning a selecting wheel (5) when the printing endless belt (7) is turned forcedly.  A movable member for restricting the rotation of the selecting wheel (5) is used, and a movable stopper (14) is moved when an excessively strong force is exerted on the selecting wheel (5) or printing endless belt (7). A stopper receiving member (15) brought into contact with an elastic portion (14B) of the stopper (14) is provided. Engagement of driving projections (7E) with the elastic portion (14B) in accordance with the movement of the printing endless belt (7) makes the movable stopper member (14) movable.
Patent NZ-335107-A (NZ)
Title: Trichoderma cellulase isolated from a culture of Trichoderma longibrachiatum with an estimated molecular weight of 95-105 kD and an estimated pH optimum of 5.0 at 338 Kelvin and ph 4.0 at 318 and 328 Kelvin
Inventor: CLARKSON KATHLEEN A
IPC: A23L7/104
Filed: 1997-10-07
Abstract: The present invention relates to a purified cellulase composition, where the purified cellulase composition corresponding to a naturally occurring cellulase produced during a fermentation of Trichoderma longibrachiatum which exhibits a molecular weight of about 95-105 kD as measured on SDS-PAGE gel and a pI of about 5.6-6.8 as measured on an IEF gel. Also claimed is a method for preparing a purified cellulase composition comprising the steps: a)	preparing a fermentation culture of a microorganism which produces a cellulase composition corresponding to a naturally occurring cellulase produced during fermentation of Trichoderma longibrachiatum which exhibits a molecular weight of a bout 95-105 kD as measured on SDS-PAGE gel and a pI of about 5.6-6.8 as measured on an IEF gel and b)	separating the cellulase from the microorganisms to form a purified cellulase composition
Patent NZ-335852-A (NZ)
Title: Genes coding for amino acid deacetylases with specificity for n-acetyl-l-phosphinothricin, their isolation and their use
Inventor: BARTSCH KLAUS
IPC: C12N1/21
Filed: 1997-12-03
Abstract: DNA molecules that code for deacetylases or proteins having the biological activity of a deacetylase, and transgenic plant cells which are transformed with the DNA molecules. These molecules can be used to produce plants having parts that can be deliberately destroyed, that is plants that have male or female sterility, by the specific expression of a deacetylase gene.
Patent NZ-338005-A (NZ)
Title: Welding two spaced ends of two pipe sections with a welding bug having a wire feeder
Inventor: STAVA ELLIOTT K
IPC: B23K9/073
Filed: 1999-09-23
Abstract: An apparatus and method of short circuit arc welding two spaced ends 70 of two pipe sections at a groove 72 between the two pipe sections, is disclosed.  The method and apparatus include the use of a cored metal electrode 50 and moving the electrode toward the groove as the electrode is moved along the groove and about the outer peripheral surface of the pipe sections during the welding operation.  Cored electrode 50 is melted by an electric cycle which comprises a transfer portion and a plasma portion.  The plasma portion is controlled to bridge the gap between the pipe sections for laying a root bead along the groove.  The cored electrode is preferably a self-shielding electrode and includes alloying components in the core to form a root bead having a substantially similar composition as the composition of the two pipe sections.  The apparatus and method has a selector to control the polarity of the individual cycles of a total welding procedure.
Patent NZ-501972-A (NZ)
Title: In situ sensitisation of aqueous explosives by the formation of a gas-in-liquid emulsion
Inventor: QUINTANA ANGULO JOSE RAMON
IPC: C06B47/00
Filed: 1997-11-26
Abstract: Described is a method for sensitizing in situ aqueous explosives before charging the mine holes.  The method comprises the formation of an emulsion or dispersion gas-in-liquid from a low sensitivity or non explosive matrix product which consists of a liquid mixture in solution, emulsion or suspension of oxidant in fuel, and a gas.  The density of the final explosive product can be varied as a function of the gas flow rate and can be controlled before introducing it into the hole.  The installation comprises a tank (1) with the matrix product, a gas reserve (10), a mixture (5), a pump (3) and a gas flow rate regulating device (8) and optionally a tank (2) with a gas bubble stabilizing agent, a dosing pump (4) and a flow meter (7).
Patent NZ-502645-A (NZ)
Title: Dermatological compositions for treatment of the symptoms of hypersensitivity and cutaneous intolerance
Inventor: FRUCTUS ALAIN E
IPC: A61K8/31
Filed: 1998-08-28
Abstract: Dermatological and/or cosmetic compositions that allow the appearance of the symptoms of hypersensitivity and cutaneous intolerance to be avoided.  The compositions comprise an effective combination of microbial proliferation inhibitors containing; a first microbial proliferation inhibitor which comprises an aqueous mixture of sodium polyacrylate, at least one polyol, and at least one glycol compound selected from methoxydiglycol, ethoxydiglycol, propoxydiglycol, butoxydiglycol, triethyleneglycol monopropyl ether, ethoxyethanol acetate, ethoxydiglycol acetate and, polyethylene and polypropylene glycols; and a second microbial proliferation inhibitor which comprises at least one monoalkyl glycerine ether or an ester thereof of the formula R4OCH2CH(OH)CH2OR5  in which R4 is a straight or branched chain alkyl group containing 6 to 24 carbon atoms and R5 is H or a straight or branched alkanoyl group containing 8 to 24 carbon atoms. Also described is the local or topical application of this composition along with its use as a medicament for the treatment of the symptoms of cutaneous hypersensitivity and intolerance, psoriasis, atopy, acne, and cutaneous ageing, or for the prevention of the symptoms of benign estival light eruption.
Patent NZ-503551-A (NZ)
Title: PDE4 inhibitors for the treatment of inflammatory skin diseases
Inventor: GRISWOLD DON E
IPC: C07D473/04
Filed: 1998-10-16
Abstract: Derivatives of 8-substituted xanthines used in the prophylaxis or therapy of diseases or disorders which have a pruritic component.  The derivatives described have PDE4 inhibitor activity and are used in medicaments for the treatment of inflammatory skin conditions.
Patent NZ-508503-A (NZ)
Title: Methods of inhibiting corrosion using isomers of chloro- methylbenzotriazole
Inventor: ANDERSON SYDIA B
IPC: C23F11/14
Filed: 1999-03-17
Abstract: The use of halo-benzotriazoles as corrosion inhibitors in aqueous systems is disclosed. Specific isomers of chloro- methylbenzotriazole  were  found  to   be   more   effective corrosion  inhibitors than tolyltriazole in the presence  of chlorine. A method of inhibiting corrosion of metal surfaces contacted by   an   aqueous  system  being  treated  with  a   halogen comprising adding to said aqueous system being treated  with a   halogen,  6-chloro-5-methylbenzotriazole  in  an  amount effective for the purpose of inhibiting corrosion of.
Patent NZ-508578-A (NZ)
Title: Fatty acid esters of phytosterol or phytostanol containing compositions useful in food products
Inventor: WESTER INGMAR
IPC: A23L33/11
Filed: 1999-05-06
Abstract: A sterol and/or stanol fatty acid ester composition wherein the fatty acid moiety comprises a blend of less than 7% by weight of saturated fatty acids and more than 50% by weight of polyunsaturated fatty acids is useful as a food product.
Patent NZ-508645-A (NZ)
Title: Compositions comprising phytosterol and/or phytostanol having enhanced solubility and dispersability and the use of these compositions to lower serum cholesterol
Inventor: STEWART DAVID JOHN
IPC: A23L1/30
Filed: 1999-06-07
Abstract: A formulation which is suitable for incorporation into foods, beverages, pharmaceuticals and nutraceuticals and which comprises one or more phytosterols, phytostanols or mixtures of both, is selected from the group consisting of microemulsion, a self-emulsifying system, a solid dispersion, a cyclodextrin complex, and a hydrotope, and wherein in each formulation the phytosterols and phytostanols are solubilised and dispersed therein. Also described are pharmaceutical compositions, foods and beverages comprising the formulation described above. The formulation described above is useful for lowering serum cholesterol in animals. Also described is a method of increasing one of the solubility or dispersibility of phytosterols and phytostanols comprising forming a phytosterol-based or phytostanol-based formulation selected from: microemulsion, a self-emulsifying system, a solid dispersion, a cyclodextrin complex, and a hydrotope.
Patent NZ-512278-A (NZ)
Title: Nanocapsules having two different water soluble polymers covalently crosslinked to the surface of a liposome
Inventor: PANZNER STEFFEN
IPC: A61K47/26
Filed: 1999-11-15
Abstract: An method of producing nanocapsules having a diameter of 50 nm to 10mm comprises binding a polymer P1 to the liposome surface in an aqueous solution to form a coating which is then covalently crosslinked in an aqueous solution with a polymer P2 which is different from polymer P1 and additional polymer layers are optionally coated by crosslinking.  P1 and P2 can be protein or carbohydrates or synthetic polymers having functional groups such as amino, carboxy, thiol, hydrazo, hydroxyl, acidic hydrogen, aldehyde or ester groups.
Patent NZ-517183-A (NZ)
Title: Enhancements for seams in on-machine-seamable papermaker's fabrics
Inventor: KORNETT GLENN J
IPC: D03D23/00
Filed: 2002-02-13
Abstract: An on-machine-seamable papermaker's fabric (10), which may be produced by modified endless weaving, includes machine-direction (MD) (24) and cross-machine-direction (CD) yarns (22). When so produced, the MD yarns (24) weave continuously back and forth between the two widthwise edges of the fabric, each time forming a seaming loop at one of the two widthwise edges. Interwoven with at least one of the two sides, top and bottom, of the seaming loops at one or both widthwise edges are at least two additional CD yarns. The additional CD yarns interweave with the top and/or bottom of the seaming loops in a leno weave, which keeps the seaming loops in a common position vertically relative to the plane of the papermakers fabric, locks the seaming loops into a desired position and orientation with their planes perpendicular to that of the papermaker's fabric (10).
Patent NZ-518454-A (NZ)
Title: Viruses for the treatment of cellular proliferative disorders
Inventor: COFFEY MATTHEW C
IPC: A61K35/13
Filed: 2000-11-08
Abstract: The application describes the use of one or more viruses selected from the group consisting of modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus orf virus for the manufacture of a medicament for treating ras-mediated proliferative disorder in a mammal in need thereof. A pharmaceutical composition containing a plurality of viruses selected from the above group and a pharmaceutically acceptable excipient is described, as is a method for treating a population of cells comprising a neoplasm suspected of having an activated ras pathway.
Patent NZ-518549-A (NZ)
Title: Refrigeration device, such as a refrigerator, a refrigerator/freezer combination or the like
Inventor: NUIDING WOLFGANG
IPC: F25B39/04
Filed: 2000-10-12
Abstract: The invention relates to a refrigeration device (10) with a heat-insulating housing (11) that has at least one door and with a heat exchanger that is used as a condenser (20). The refrigeration device further comprises a collecting container (16) that collects the melt water produced in the defrost operation of the refrigeration device. The problem one is often faced with in such refrigeration devices is that the running times of the refrigerant compressor (14) are substantially reduced owing to the highly efficient heat insulation so that the evaporation of the melt water favored by the heat dissipated by the compressor (14) is reduced to such an extent that it cannot be excluded that the water in the collecting container will spill over. According to the invention, this problem is solved by removing the melt water from the container (16) to a certain minimum level by means of an absorbent, hydrophilic material (23), said absorbing material (23) being exposed to the heat dissipated by the condenser (20) to accelerate the evaporation rate of the absorbed melt water.
Patent NZ-521392-A (NZ)
Title: Methods for sterilizing biological materials involving stabilization and irradiation
Inventor: KENT RANDALL S
IPC: A61M1/36
Filed: 2001-03-23
Abstract: Methods are disclosed for sterilizing biological products to reduce the level of active biological contaminants such as viruses, bacteria, yeasts, moulds, mycoplasmas and parasites. The figure shows the protective effects of certain stabilizers on lyophilised anti-insulin monoclonal antibody exposed to 45 kGy of low dose gamma irradiation.
Patent NZ-522308-A (NZ)
Title: Server presents product or part usage information to remote inspection
Inventor: LODA DAVID C
IPC: G06Q10/06
Filed: 2002-10-31
Abstract: An integrated system comprising a product on a movable platform, a server communicating with the product and a webpage hosted by the server, that enables two-way communications between product and server. The webpage has a portal located remotely from the server and software tools for analyzing the data received and can organize them accordingly.
Patent NZ-523944-A (NZ)
Title: Connection between purlin and rafter being saddle slidable along rafter
Inventor: DAGG HAYDEN
IPC: E04B7/00
Filed: 2000-09-25
Abstract: Purlin to rafter coupling 30 has a saddle member 52 for location and sliding on rafter 20B. The coupling also has a purlin fixture to secure or locate an end of purling 14B. By use of such coupling outer surfaces of rafter and purlin are substantially flush.
Patent NZ-525613-A (NZ)
Title: Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
Inventor: AISSAOUI HAMED
IPC: A61P3/04
Filed: 2001-12-19
Abstract: A compound of general formulae (I), (II) and (III) are disclosed. Pharmaceutical compounds containing abovementioned compounds are also disclosed for the treatment of disorders associated with oxerin, such as obesity and sleep disorders.
Patent NZ-527773-A (NZ)
Title: Transponder memory with lock region
Inventor: URBAS DONALD J
IPC: A01K11/00
Filed: 2001-02-09
Abstract: A memory for a transponder that comprises a data region and a user lock region, the data region storing a plurality of characters and the user lock region including a plurality of bits. The number of bits in the user lock region at least equals the number of characters in the data region, each bit of the user lock region corresponds to a respective character and each of the bits in the user lock region indicating a locked or unlocked status of the respective character in the data region. Wherein the user lock region and the data region are physically distinct from each other. (62) Divided out of 515161
Patent NZ-528324-A (NZ)
Title: A building component
Inventor: OLIVER JOHN EDWARD
IPC: E04B1/64
Filed: 2003-09-18
Abstract: A building component comprises a weight-bearing spacer which is used in a row along the length of the bottom plate of a frame. Preferred spacers are typically made from a moulded plastics material, or bent sheet metal. Functions include rigidly supporting the bottom plate just above the floor of a building under construction and thereafter, so that water cannot collect on the floor and be damned against the bottom plate, separating the floor plate from contact with possible damp surfaces throughout the life of the building to minimise the risk of water-promoted decay and so that treated bottom plate timber is not needed, providing a base on which to lie an edge of a wall panel, maintaining channels for carrying wiring beneath the floor plate, and for maintaining separation of cladding from contact with underlying walls.
Patent NZ-532871-A (NZ)
Title: Diindolylmethane (LIM) for the treatment of human papilloma virus infection, orally and/or topically, with and without an immune potentiating steroid
Inventor: ZELIGS MICHAEL A
IPC: A61K31/565
Filed: 2002-10-22
Abstract: Disclosed are compositions that comprise the phytochemical Diindolylmethane, alone or in combination with immune potentiating steroids or aloe vera. These compositions are utilized in the manufacture of a medicament to treat subjects suffering from common cutaneous warts (verrucae) and Human Papilloma Virus (HPV) related conditions of the oropharynx, larynx, genitalia, and uterine cervix.
Patent NZ-534999-A (NZ)
Title: Crystalline polymorphic form c of irinotecan hydrochloride
Inventor: FORINO ROMUALDO
IPC: A61K31/4745
Filed: 2003-02-26
Abstract: Disclosed herein is a polymorphic form "c" of crystalline irinotecan hydrochloride of formula (I) characterized by providing an X-ray powder diffraction pattern comprising 2-theta angle values of about 9.15; about 10.00; about 11.80; about 12.20; about 13.00 and about 13.40, and which provides an infrared spectrum containing peaks at 1757, 1712 and 1667 cm-1. A process for preparing this polymorphic form "c" of crystalline irinotecan hydrochloride, pharmaceutical compositions comprising this polymorphic form as an active ingredient and the use thereof as a therapeutic agent for treating cancer are also disclosed.
Patent NZ-541280-A (NZ)
Title: Use of a pyrethroid or pyrethrin in combination with a nicotinic agonist to repel insects
Inventor: MENCKE NORBERT
IPC: A01N65/12
Filed: 2004-01-05
Abstract: Disclosed is the use of a pyrethroid or pyrethrin in combination with a nicotinergic acetylcholine receptor agonist of arthropods for repelling arthropods.